The present invention relates to a bonded nonwoven fabric generally including absorbent staple fibres and having bonding stripes of relatively high fibre entanglement density extending along the fabric and into the fabric from at least one face thereof. A method of producing a bonded nonwoven fabric suitable for use as an absorbent layer in a wound dressing is also described.

The present invention relates to a bonded nonwoven fabric generally including absorbent staple fibres and having bonding stripes of relatively high fibre entanglement density extending along the fabric and into the fabric from at least one face thereof. A method of producing a bonded nonwoven fabric suitable for use as an absorbent layer in a wound dressing is also described.

The present disclosure provides an antimicrobial alginate fiber, a method for manufacturing an antimicrobial alginate fiber dressing thereof, and an application thereof. When the cationic polymer polyhexamethylene guanide salt is mixed with the anionic polymer alginate, the antimicrobial activity of the guanide salt is quickly passivated. The present disclosure achieves a lower content of polyhexamethylene guanide salt in an alginate dressing with good long-term antimicrobial activities. The polyhexamethylene guanide salt has a low dissolution rate, and significantly reduces a potential risk of carcinogenicity, mutagenicity and reproductive toxicity.

The present disclosure provides an antimicrobial alginate fiber, a method for manufacturing an antimicrobial alginate fiber dressing thereof, and an application thereof. When the cationic polymer polyhexamethylene guanide salt is mixed with the anionic polymer alginate, the antimicrobial activity of the guanide salt is quickly passivated. The present disclosure achieves a lower content of polyhexamethylene guanide salt in an alginate dressing with good long-term antimicrobial activities. The polyhexamethylene guanide salt has a low dissolution rate, and significantly reduces a potential risk of carcinogenicity, mutagenicity and reproductive toxicity.

A composite fiber sponge containing sulforaphane is produced by the step of subjecting a composite liquid to a molding treatment and a crosslinking treatment. The composite liquid contains a composite fiber including an extract of a Brassicaceae plant, a polysaccharide, and a carboxymethyl cellulose fiber. The extract of the Brassicaceae plant contains the sulforaphane. A composite fiber material containing sulforaphane is also disclosed.

A composite fiber sponge containing sulforaphane is produced by the step of subjecting a composite liquid to a molding treatment and a crosslinking treatment. The composite liquid contains a composite fiber including an extract of a Brassicaceae plant, a polysaccharide, and a carboxymethyl cellulose fiber. The extract of the Brassicaceae plant contains the sulforaphane. A composite fiber material containing sulforaphane is also disclosed.

The present invention provides a composite fiber which comprises an alginate fiber, a polymer material, an antibacterial agent, and a plasmid encoding growth factor-gene. The present invention also provides a wound dressing, wherein the wound dressing comprises a composite fiber as described above. The composite fibers prepared according to the present invention are capable of releasing the antibacterial agent and the growth factor gene, not only to reduce microorganism growth, but also to secrete growth factors in a wound site through transfection, thereby promoting wound healing.

The present invention provides a composite fiber which comprises an alginate fiber, a polymer material, an antibacterial agent, and a plasmid encoding growth factor-gene. The present invention also provides a wound dressing, wherein the wound dressing comprises a composite fiber as described above. The composite fibers prepared according to the present invention are capable of releasing the antibacterial agent and the growth factor gene, not only to reduce microorganism growth, but also to secrete growth factors in a wound site through transfection, thereby promoting wound healing.

The present invention discloses an algae modified pp spunbond non-woven fabric, which contains 0.1-2% of alginate. The algae modified pp spunbond non-woven fabric has a moisture regain of 0.2-3.5%, and an antibacterial rate 98%. The algae modified pp spunbond non-woven fabric prepared in the invention contains modified alginic acid, and also has hydrophilic functional groups, such as hydroxyl and amido groups, and hydrophobic functional groups such as branched alkyl groups. After spinning with pp into non-woven fabrics, protons can be both generated and received, so that when liquid is encountered on the surface of non-woven fabrics, the surface tension of liquid can be significantly reduced; additionally, there are a large number of gaps in the dense interpenetrating network structure formed by the modified alginic acid, which forms a structure like sponge having good hygroscopicity; moreover, the algae modified pp spunbond non-woven fabric absorbs water rapidly, the surface remains dry after absorbing water, and it can absorb many times its mass of water, so it has an excellent hydrophilicity.

A wound dressing, including fibers containing silver ions. The fibers are manufactured by dissolving silver nitrate into a polymer solution in the substantial absence of light, and then extruding the obtained solution into fibers by wet spinning process. The silver content of the wound dressing is between 0.01-10% by weight, and preferably 0.1-7% by weight.